The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses

Faraz Ahmed, David Hirschl, Kapil Wattamwar, Jaron Tepper, Lyndon Lee, Jacob Cynamon

Research output: Contribution to journalArticlepeer-review

Abstract

The purpose of this study was to investigate the safety and effectiveness of the transfemoral transcaval (TFTC) liver biopsy technique in patients with hepatic masses with relative contraindications to percutaneous biopsy and/or mass location abutting the inferior vena cava. The medical records of 16 patients (56% men; age range, 21–88 years) who underwent TFTC biopsy of hepatic masses (ranging in diameter from 2.1 to 13.2 cm) from September 2015 to August 2021 were reviewed. Histopathologic diagnoses were made in 15 of 17 (88%) procedures. Two adverse events were noted: worsened preexisting hemobilia requiring embolization in 1 patient, and a decrease in hematocrit level in another patient, requiring only observation. In conclusion, this report showed that the TFTC technique is a relatively safe and effective method for sampling hepatic masses in select cases.

Original languageEnglish (US)
Pages (from-to)1230-1233
Number of pages4
JournalJournal of Vascular and Interventional Radiology
Volume33
Issue number10
DOIs
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'The Use of the Transfemoral Transcaval Liver Biopsy Technique for Biopsies of Hepatic Masses'. Together they form a unique fingerprint.

Cite this